Cargando…

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus

Evidence from previous studies suggests a protective effect of metformin in patients with colorectal cancer (CRC). The aim of this study was to examine the associations between metformin use and overall survival (OS) and disease-free survival (DFS) in CRC patients with type 2 diabetes mellitus (DM)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarhini, Zeinab, Manceur, Kamelia, Magne, Julien, Mathonnet, Muriel, Jost, Jeremy, Christou, Niki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300732/ https://www.ncbi.nlm.nih.gov/pubmed/35859114 http://dx.doi.org/10.1038/s41598-022-16677-3

Ejemplares similares

The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials
por: Hervieu, Céline, et al.
Publicado: (2021)

Personalized Therapy and Liquid Biopsy—A Focus on Colorectal Cancer
por: Christou, Niki, et al.
Publicado: (2021)

E-cadherin: A potential biomarker of colorectal cancer prognosis
por: Christou, Niki, et al.
Publicado: (2017)

5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
por: Blondy, Sabrina, et al.
Publicado: (2020)

Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
por: Powell, Marta K., et al.
Publicado: (2019)

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer
por: Al Omari, Amal, et al.
Publicado: (2018)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
por: Christou, Niki, et al.
Publicado: (2019)

ONCOGRAM: study protocol for the evaluation of therapeutic response and survival of metastatic colorectal cancer patients treated according to the guidelines of a chemosensitivity assay, the Oncogramme®
por: Mathonnet, Muriel, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
por: Wang, Yaodu, et al.
Publicado: (2017)

Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
por: Blondy, Sabrina, et al.
Publicado: (2020)

Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
por: Saito, Akira, et al.
Publicado: (2020)

Neurotrophins and their involvement in digestive cancers
por: Blondy, Sabrina, et al.
Publicado: (2019)

Long‐term survival after surgery of pancreatic primary squamous cell carcinoma: A case report and literature review
por: Taibi, Abdelkader, et al.
Publicado: (2019)

Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept
por: Bounaix Morand du Puch, Christophe, et al.
Publicado: (2021)

The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)

Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome
por: Christou, Niki, et al.
Publicado: (2018)

Neurotensin pathway in digestive cancers and clinical applications: an overview
por: Christou, Niki, et al.
Publicado: (2020)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016)

Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival
por: Akil, Hussein, et al.
Publicado: (2011)

Metformin Use Is Not Associated With B(12) Deficiency or Neuropathy in Patients With Type 2 Diabetes Mellitus in Qatar
por: Elhadd, Tarik, et al.
Publicado: (2018)

A Label-Free Cell Sorting Approach to Highlight the Impact of Intratumoral Cellular Heterogeneity and Cancer Stem Cells on Response to Therapies
por: Hervieu, Céline, et al.
Publicado: (2022)

Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)

Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)

Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
por: Liu, Feifei, et al.
Publicado: (2016)

Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017)

Impact of Metformin Use on Survival in Patients with Gastric Cancer and Diabetes Mellitus Following Gastrectomy
por: Chung, Wai-Shan, et al.
Publicado: (2020)

Intraperitoneal Chemotherapy for Peritoneal Metastases: Technical Innovations, Preclinical and Clinical Advances and Future Perspectives
por: Christou, Niki, et al.
Publicado: (2021)

C-reactive protein is a predictive factor for complications after incisional hernia repair using a biological mesh
por: Janet, Julien, et al.
Publicado: (2021)

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus
por: Sun, Lin, et al.
Publicado: (2011)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin‐Hsiao
Publicado: (2018)

Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2020)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang, Qi, et al.
Publicado: (2020)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
por: Weiss, Tracey, et al.
Publicado: (2021)

The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
por: Choi, Younak, et al.
Publicado: (2016)

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dpmp40kvkq0pvq9vphld0rfuam